Chief Financial Officer · C4 THERAPEUTICS, INC. · C4 Therapeutics, Inc.
Side
SELL
Value
$122K
Shares
45.2K
Price
$2.71
Executed
Nov 12, 2026
Disclosed
Nov 13, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 12 executedNov 13, 2026 disclosed
CCCC · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · CCCC
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
KENDRA ADAMS filed this Form 4 reporting a open-market sale of CCCC on Nov 12, 2026. It became public on Nov 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
KENDRA ADAMScik:0001991929
Issuer
C4 THERAPEUTICS, INC.cik:0001662579
Revision history · 0
No field has changed since this record was first ingested.
